Carcinoma, Non-Small-Cell Lung

• 1230.5.00104 Boehringer Ingelheim Investigational Site — Edmonton, Alberta, Canada
• 1230.5.00114 Boehringer Ingelheim Investigational Site — Kelowna, British Columbia, Canada
• 1230.5.00109 Boehringer Ingelheim Investigational Site — Surrey, British Columbia, Canada
• 1230.5.00107 Boehringer Ingelheim Investigational Site — Vancouver, British Columbia, Canada

• Genesis Cancer Center — Hot Springs, Arkansas, United States
• Little Rock Hematology/Oncology Associates — Little Rock, Arkansas, United States
• Highlands Oncology Group — Springdale, Arkansas, United States
• Medical Oncology Care Associates — Orange, California, United States

• 1200.22.28 Boehringer Ingelheim Investigational Site — Bakersfield, California, United States
• 1200.22.32 Boehringer Ingelheim Investigational Site — Beverly Hills, California, United States
• 1200.22.4 Boehringer Ingelheim Investigational Site — Mission Hills, California, United States
• 1200.22.16 Boehringer Ingelheim Investigational Site — Orange, California, United States

• San Francisco, California, United States
• Boston, Massachusetts, United States
• Chapel Hill, North Carolina, United States
• Salt Lake City, Utah, United States

• VA Palo Alto Healthcare System — Palo Alto, California, United States
• Santa Clara Valley Medical Center — San Jose, California, United States
• Stanford University School of Medicine — Stanford, California, United States

• Hopital Européen Georges Pompidou — Paris, France

Not specified

• Research Site — Concord, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Boston, Massachusetts, United States

• Research Site — Matsuyama, Ehime, Japan
• Research Site — Isehara, Kanagawa, Japan
• Research Site — Okayama, Okayama-ken, Japan
• Research Site — Sayama, Osaka, Japan

Not specified